Another Print Package

Lorem ipsum dolor sit amet, consectetuer adipiscing elit, sed diam nonummy nibh euismod tincidunt ut laoreet dolore magna aliquam erat volutpat.

FL3 Print Package

Design

Awesome Pencil Poster

Design

Portfolio typography

Design

Flatsome Poster Print

Design

Magazine

Design

Home
About
Imatinib for COVID-19
News
Exvastat
Contact

This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 101005142.

This Joint Undertaking receives support from the European Union’s Horizon 2020
research and innovation programme and EFPIA.

IMPENTRI IMI2Follow

6 Oct

Congratulations to the team on their paper "Elevated acute phase proteins affect pharmacokinetics in COVID-19 trials: lessons from the CounterCovid imatinib study, accepted into #PSPJournal.
See it here https://ascpt.onlinelibrary.wiley.com/doi/10.1002/psp4.12718
@ASCPTjournals

Reply on Twitter 1445711357274255362 Retweet on Twitter 14457113572742553621 Like on Twitter 14457113572742553621 Twitter 1445711357274255362

27 Aug

#ESCCongress 2nd talk by Dr Duijvelaar 🇳🇱
Promising results for #Imatinib & announcement for 3 new @WHO solidarity trials ‼️

#Covid19 #vaccination strongly advised by entire panel as risk for post💉 myo-/peri-carditis much lower than 4 acute 🦠

@avolgman @Hragy @NitiCardio

Reply on Twitter 1431148653570404354 Retweet on Twitter 14311486535704043546 Like on Twitter 14311486535704043548 Twitter 1431148653570404354

10 May 2021

International COVID-19 trial to restart with focus on immune responses https://www.nature.com/articles/d41586-021-01090-z

Reply on Twitter 1391712907021406210 Retweet on Twitter 1391712907021406210 Like on Twitter 13917129070214062102 Twitter 1391712907021406210

Home
About
Imatinib for COVID-19
News
Exvastat
Contact